Skip to content
MamaGLP — home

Head to head for first-timers

Eden vs Zealthy

Eden and Zealthy both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.

Eden

Higher score

Rank #2 for first-timers · Grade A−

Mama-Match

Best for: Moms who want more clinical hand-holding and don't mind paying a bit more for it.

Visit Eden
vs

Zealthy

Rank #293 for first-timers · Grade C

Mama-Match

Best for: Nothing, while the federal case is open. It stays on the board for transparency, not as a suggestion.

Visit Zealthy

The verdict for a first step

Higher Mama-Match Score: Eden

Eden edges out Zealthy on the Mama-Match Score, 90 to 39 (A− vs C). Moms who want more clinical hand-holding and don't mind paying a bit more for it.

Zealthy is still a genuine option — ⛔ FDA warning letter #716501 (Sept. 2025) and, in April 2026, the FTC and DOJ moved to seize the company and freeze its assets. Read that first. Weigh the six first-timer factors below against your own priorities.

Side by side on all six factors

Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.

Eden Zealthy
Gentle, easy start8955
Eden
Zealthy
Honest, upfront pricing8830
Eden
Zealthy
Real clinician support9325
Eden
Zealthy
Available nationwide9545
Eden
Zealthy
Ongoing help & check-ins9045
Eden
Zealthy
Simple, fair cancellation8822
Eden
Zealthy

Price, access and features

DetailEdenZealthy
Mama-Match Score90/100 · A−39/100 · C
Overall rank#2#293
Semaglutide$249/mo$135/mo
Tirzepatide$349/mo$225/mo
CoverageAll 50 statesMost states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Mama-Match

Eden

Rank #2 · Grade A−

What we like

  • Careful intake and clear clinician involvement — they don't just mail you a vial
  • Nationwide, with semaglutide and tirzepatide both on the menu
  • Transparent about how the program and its partner pharmacies actually work

The caveats

  • ⛔ FDA warning letter #728279, dated June 8, 2026, to Eden Health International Inc. dba Eden, for false or misleading claims and misbranding — the letter names tryeden.com
  • Pricier than the cheapest entry-level tiers
  • Compounded only — no path to brand-name Wegovy or Zepbound

Mama-Match

Zealthy

Rank #293 · Grade C

What we like

  • Low, published monthly pricing for semaglutide and tirzepatide
  • Coverage in most states with a fast, low-friction signup
  • Straightforward compounded model — you see the cost before you commit

The caveats

  • ⛔ FDA warning letter #716501, dated September 9, 2025, to FitRX, LLC dba Zealthy, for unlawful sale of unapproved and misbranded drugs over the internet — the letter names its own site
  • April 2026: the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation and review manipulation
  • The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent — the government's words are that Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts". These are allegations, not findings; the case is ongoing

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing Eden and Zealthy with the other providers we review for women.

Or browse the full comparison hub.